Metabolic Health Outweighed BMI in Predicting Cardiovascular Risk Across Cohorts
The long-standing habit of treating body mass index as the main clinical shorthand for cardiovascular risk gets a harder look in this meta-analysis of longitudinal cohort studies. Across 51 publications representing 44 studies, investigators separated participants into combined BMI-metabolic health phenotypes and tracked incident cardiovascular disease, coronary heart disease, myocardial infarction, stroke, and heart failure. The central message is blunt: excess weight mattered, but metabolic health mattered more, and the combination of the two carried the steepest hazard.
Compared with metabolically healthy normal-weight individuals, those with metabolically unhealthy obesity had markedly higher risk across every outcome examined. The pooled hazard ratios were 2.10 for cardiovascular disease, 1.97 for coronary heart disease, 2.20 for myocardial infarction, 1.55 for stroke, and 2.05 for heart failure. Those are not subtle shifts in relative risk. They describe a pattern in which cardiometabolic dysfunction appears to push the arterial tree, myocardium, and cerebrovascular circulation toward event accumulation far more aggressively than adiposity alone.
The Combined Burden of Excess Weight and Metabolic Dysfunction
The analysis reinforces a concept that has become increasingly difficult to ignore in preventive cardiology: obesity is not a single biological state. Two people with the same BMI can carry very different vascular risk depending on whether they have insulin resistance, dyslipidemia, hypertension, impaired glucose handling, or other markers of metabolic instability. In that setting, adipose tissue becomes less a passive storage depot and more an active endocrine and inflammatory organ.
A dose-response relationship emerged for both higher BMI and poorer metabolic health in relation to cardiovascular disease, coronary heart disease, myocardial infarction, and heart failure. The pattern is biologically plausible. Visceral adiposity promotes chronic low-grade inflammation, endothelial dysfunction, altered lipid trafficking, and insulin resistance, all of which accelerate atherosclerotic plaque formation and myocardial remodeling. Once metabolic unhealthiness is established, the vascular consequences extend beyond simple weight category labels.
One sentence captures the clinical sting of the findings: BMI alone did not define risk well enough.
Normal Weight Did Not Guarantee Protection When Metabolism Was Unhealthy
The most clinically disruptive observation was not confined to obesity. Associations for metabolically unhealthy normal weight individuals often exceeded those seen in metabolically healthy obese individuals. In practice, this means a patient who looks “normal” by weight criteria can still carry a cardiovascular profile that is more dangerous than that of a heavier patient with preserved metabolic function.
That finding has immediate relevance for risk assessment in clinics that still rely too heavily on body size as a proxy for health. Normal-weight adults with central adiposity, occult insulin resistance, adverse lipid profiles, or elevated blood pressure may move through routine care with less scrutiny precisely because they do not fit the visible stereotype of metabolic risk. The biology does not cooperate with that shortcut. Cardiometabolic injury tracks with underlying physiology, not appearance.
This is also where the heart failure signal deserves attention. Heart failure risk rose substantially in metabolically unhealthy obesity, suggesting that the downstream burden is not limited to plaque rupture or ischemic events. Chronic metabolic stress can drive myocardial fibrosis, diastolic dysfunction, neurohormonal activation, and structural remodeling long before overt decompensation becomes clinically obvious.
Stroke Followed a Different Pattern
Stroke was the outcome where metabolic health appeared to dominate most clearly. The meta-analysis found that poor metabolic health was the primary determinant of stroke risk, while the obesity effect itself was less prominent than it was for the other cardiovascular endpoints. This distinction is clinically meaningful because cerebrovascular disease often reflects a mixture of large-artery atherosclerosis, small-vessel disease, blood pressure burden, and glycemic injury, each of which is closely tied to metabolic dysfunction.
A person can therefore carry substantial stroke risk without extreme adiposity if hypertension, dysglycemia, or other metabolic abnormalities are present. The vascular bed in the brain is especially sensitive to these chronic insults. Endothelial dysfunction, impaired autoregulation, and arteriolar remodeling can translate metabolic stress into ischemic events even when body weight does not appear dramatically elevated.
Why This Matters for Risk Stratification and Prevention
The findings argue for a more granular approach to cardiometabolic assessment. Weight remains relevant, but it should not be used as a surrogate for the real drivers of vascular injury. Metabolic phenotype adds information that BMI alone cannot provide, especially when deciding who needs earlier screening, more aggressive lifestyle counseling, or tighter control of blood pressure, glucose, and lipids.
The study also helps explain why some patients with obesity do not experience the same degree of cardiovascular harm as others. “Metabolically healthy obesity” is not a guarantee of benign long-term prognosis, but it may represent a lower-risk state than obesity accompanied by metabolic abnormalities. Even so, the risk gradient in this analysis suggests that metabolic preservation should not be mistaken for full protection, particularly over longer horizons in cohort follow-up.
Across outcomes, the combination of higher BMI and metabolic unhealthiness consistently produced the greatest burden. That aligns with what clinicians see at the bedside: the patient with central adiposity, elevated triglycerides, glucose intolerance, and hypertension does not merely add one risk factor to another; the biology compounds. Endothelial stress, inflammatory signaling, and atherothrombotic propensity reinforce each other, producing a risk profile that is more than the sum of its parts.
Limits of the Evidence Base Still Shape Interpretation
This was a systematic review and meta-analysis of cohort studies, which gives it broad observational reach but not the causal certainty of a randomized trial. The summary provided here does not include the full range of between-study variation, phenotype definitions, or adjustment strategies used across cohorts, all of which can influence pooled estimates. BMI and metabolic health categories also depend on how each study defined metabolic unhealthiness, and those definitions are not always uniform across populations.
Even with those constraints, the direction of travel is hard to miss. Cardiovascular risk rose as metabolic health worsened, rose as BMI increased, and rose highest when both were present together. Stroke followed its own pattern, with metabolic health carrying the heavier load. The next question for prevention is not whether obesity matters, but how quickly clinical practice can stop using body size as a stand-in for metabolic danger.